Potential Role of Ultrafine Particles in Associations between Airborne Particle Mass and Cardiovascular Health by Delfino, Ralph J. et al.
934 VOLUME 113 | NUMBER 8 | August 2005 • Environmental Health Perspectives
Review
Coronary heart disease (CHD) is the leading
cause of death and hospitalization among
adults 65 or more years of age (Desai et al.
1999), which makes the identiﬁcation of pre-
ventable causes for heart disease morbidity
and mortality an important research goal.
Numerous epidemiologic time-series studies
have shown generally consistent associations of
outdoor (ambient) air pollution with cardio-
vascular hospital admissions (Burnett et al.
1995, 1997a, 1997b, 1999; D’Ippoliti et al.
2003; Le Tertre et al. 2002; Linn et al. 2000;
Mann et al. 2002; Morris et al. 1995; Peters
et al. 2001a; Poloniecki et al. 1997; Samet et al.
2000a; Schwartz 1999; Schwartz and Morris
1995; Zanobetti and Schwartz 2001; Zanobetti
et al. 2000a, 2000b). Consistent associations of
ambient air pollution have also been found
with cardiovascular mortality (Clancy et al.
2002; Dockery et al. 1993; Goldberg et al.
2001a, 2001b; Hoek et al. 2001; Kwon et al.
2001; Laden et al. 2000; Pope et al. 2004a;
Rossi et al. 1999; Samet et al. 2000b; Schwartz
et al. 1996; Wichmann et al. 2000; Zanobetti
et al. 2003). The National Research Council
(NRC) Committee on Research Priorities for
Airborne Particulate Matter has identified
research needed to explain the morbidity and
mortality associations in the time-series studies
(NRC 1998, 1999, 2001, 2004). One priority
is to identify the pathophysiologic mechanisms
and causal pollutant components driving these
associations (Seaton et al. 1995).
The causal components driving the rela-
tionship between particulate matter (PM) and
cardiovascular morbidity and mortality remain
to be identiﬁed. Historically, the difﬁculty in
accomplishing this in epidemiologic studies is
related to the common use of ambient air pol-
lution data from monitoring stations located at
central regional sites. This has led to both expo-
sure misclassification and high correlations
between different pollutants. Both of these
problems can be addressed with measurements
of personal and/or microenvironmental expo-
sures (Sarnat et al. 2000, 2001). Another prob-
lem is that the importance of particle size and
chemistry has been limited by reliance on the
same government monitoring data. In the
United States, these data generally include only
particle mass concentrations in air at two parti-
cle size cuts, PM10 (PM ≤10 µm in aerody-
namic diameter) and more recently PM2.5
(PM ≤ 2.5 µm). However, there is sufficient
reason to believe that ultraﬁne particles (UFPs;
PM < 0.1 µm) are important in morbidity and
mortality associations otherwise attributed to
larger-size fractions.
Major characteristics of UFPs that
support their potential importance include a
high pulmonary deposition efﬁciency, magni-
tudes higher particle number concentration
than larger particles, and thus a much higher
surface area. The UFP’s surface can carry large
amounts of adsorbed or condensed toxic air
pollutants (oxidant gases, organic compounds,
transition metals) (Oberdörster 2001). Many
of these toxic air pollutants have been identi-
ﬁed as having pro-inﬂammatory effects in part
through the action of reactive oxygen species
(ROS), but relevant exposure data are rarely
available to epidemiologists. Available surro-
gate measures of fossil fuel combustion such as
elemental carbon (EC) or black smoke are of
some use in this regard. Results from a study
in southern California showed that a large
proportion of urban UFPs is made up of pri-
mary combustion products from mobile
source emissions (particularly diesel and auto-
mobile exhaust) and includes organic com-
pounds, EC, and metals (Kim et al. 2002).
Because exposure to mobile emissions can be
variable across short distances and depends on
personal activity patterns, assessing such expo-
sures requires methods that go beyond the use
of government monitoring data alone. These
issues regarding the characteristics of UFPs are
more thoroughly discussed in a companion
article (Sioutas et al. 2005).
In the present review we discuss evidence
for adverse effects of air pollution on cardio-
vascular health with an emphasis on ﬁndings
that suggest a role for UFPs and related toxic
air pollutant components. To date, there are
fewer direct epidemiologic data on UFPs. We
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Numerous epidemiologic time-series studies have shown generally consistent associations of
cardiovascular hospital admissions and mortality with outdoor air pollution, particularly mass
concentrations of particulate matter (PM) ≤ 2.5 or ≤ 10 µm in diameter (PM2.5, PM10). Panel
studies with repeated measures have supported the time-series results showing associations
between PM and risk of cardiac ischemia and arrhythmias, increased blood pressure, decreased
heart rate variability, and increased circulating markers of inflammation and thrombosis. The
causal components driving the PM associations remain to be identiﬁed. Epidemiologic data using
pollutant gases and particle characteristics such as particle number concentration and elemental
carbon have provided indirect evidence that products of fossil fuel combustion are important.
Ultraﬁne particles < 0.1 µm (UFPs) dominate particle number concentrations and surface area and
are therefore capable of carrying large concentrations of adsorbed or condensed toxic air pollu-
tants. It is likely that redox-active components in UFPs from fossil fuel combustion reach cardio-
vascular target sites. High UFP exposures may lead to systemic inﬂammation through oxidative
stress responses to reactive oxygen species and thereby promote the progression of atherosclerosis
and precipitate acute cardiovascular responses ranging from increased blood pressure to myo-
cardial infarction. The next steps in epidemiologic research are to identify more clearly the puta-
tive PM casual components and size fractions linked to their sources. To advance this, we discuss
in a companion article (Sioutas C, Delfino RJ, Singh M. 2005. Environ Health Perspect
113:947–955) the need for and methods of UFP exposure assessment. Key words: cardiovascular
diseases, cytokines, diesel, epidemiology, oxidative stress, particle size, toxic air pollutants. Environ
Health Perspect 113:934–946 (2005). doi:10.1289/ehp.7938 available via http://dx.doi.org/ [Online
16 March 2005]review studies using other particle size
fractions, other particle measurements such as
black smoke, and gas-phase pollutants to pro-
vide a rationale for investigations of UFPs. The
focus of this article is on epidemiologic studies
that have followed individual subjects over
time. Several excellent reviews of experimental
data and methods can be found elsewhere
(Donaldson et al. 2001; Utell et al. 2002).
Evidence of Causal Pollutant
Components in Epidemiologic
Time-Series, Cohort, and
Cross-Sectional Studies
The National Morbidity, Mortality, and Air
Pollution Study (NMMAPS) is the largest of
the air pollution time-series studies to date
(Samet et al. 2000a, 2000b). Results show
positive associations of PM10 with cardio-
pulmonary mortality and with hospital admis-
sions for cardiovascular disease, chronic
obstructive pulmonary disease (COPD), and
pneumonia in patients 65 or more years of age
living in varied environments across up to
90 cities in the United States. A subsequent
analysis to correct for statistical errors showed
an increase of 0.34% [95% conﬁdence interval
(95% CI), 0.1–0.57] in combined cardio-
respiratory mortality for each 10 µg/m3 of air
increase in PM10 (Dominici et al. 2003).
Another reanalysis of hospitalizations in
14 U.S. cities by Janssen et al. (2002) broke
down the PM10 concentrations using informa-
tion on source categories. The authors found
that for cardiovascular admissions, and to a
lesser extent COPD admissions, PM10 from
highway vehicle and diesel emissions and from
oil combustion showed the strongest associa-
tions with the most stable regression coeffi-
cients in co-regressions with other source
categories. These ﬁndings are supported by an
analysis of PM data collected for the Harvard
Six Cities Study (Dockery et al. 1993) by
Laden et al. (2000) using elemental proﬁles of
PM2.5 samples. They showed that associations
between daily total mortality and mobile
source (largely trafﬁc related) particles for the
six metropolitan areas were twice those for
sulfate-rich coal combustion particles. This dif-
ference was most clearly demonstrated for
deaths from CHD.
Additional information regarding causal
pollutant components has come from analyses
of ambient gaseous air pollutants under U.S.
federal regulation [carbon monoxide, nitrogen
dioxide, sulfur dioxide, and ozone]. These pol-
lutants can be strongly correlated with PM in
ambient air. A European study by Katsouyanni
et al. (2001) of 29 cities showed a positive asso-
ciation between total mortality and PM10 and
that this association was not confounded by
SO2 or O3. However, they did find that in
cities with higher versus lower average NO2,
the association with PM10 was significantly
greater (0.80% vs. 0.19% increase in mortality
per 10 µg/m3 PM10, respectively). The
NMMAPS study found that PM10 associations
with mortality were largely independent of
NO2, SO2, and O3 (Samet et al. 2000a).
Goldberg et al. (2001a, 2001b), Moolgavkar
(2000), and Venners et al. (2003) have also
found robust associations between cardio-
vascular mortality and pollutant gases that
often were stronger than particle associations.
In a time-series study of the Los Angeles air
basin, Linn et al. (2000) found that signiﬁcant
associations of daily cardiovascular hospital
admissions were strongest for CO, followed by
NO2, and then much weaker associations for
PM10, but daily PM data were limited by fewer
stations. Morris et al. (1995) and Morris and
Naumova (1998) found that hospital admis-
sions for congestive heart failure (CHF) were
associated with CO independent of other
gaseous pollutants in several large U.S. cities.
Mann et al. (2002) also found signiﬁcant asso-
ciations of daily CHD hospital admissions
with NO2 and CO in Los Angeles, particularly
among cases with a secondary diagnosis of
CHF or arrhythmia. Lin et al. (2003) found
that an interquartile range increase in CO was
associated with an increase of 6.4% in daily
angina and acute myocardial infarction (MI)
emergency department visits in São Paulo,
Brazil. A time-series study of seven European
areas found cardiovascular hospital admissions,
especially CHD, were associated with SO2
(Sunyer et al. 2003). Associations between
gases and hospital admissions for CHD and
CHF have been found in several other studies
(e.g., Burnett et al. 1997b, 1999; Koken et al.
2003; Morris et al. 1995, 1998).
Some of the time-series investigators have
hypothesized that pollutant gases could be act-
ing as indicators for a causal mixture of pollu-
tants, including PM-related components.
Ambient CO is highly correlated with UFPs
near combustion sources such as freeways (dis-
cussed more fully below). Although it is possi-
ble that some of the effects detected with CO
are due to the formation of carboxyhemo-
globin in the blood and carboxymyoglobin in
muscle, reported ambient concentrations are
low (< 6 ppm). A postulated mechanism for
increased susceptibility to low CO doses is the
attainment of a nominal threshold of reduced
O2 transport to the heart and further compro-
mised cardiac myoglobin, particularly in CHF
patients (McGrath 2000).
Additional evidence of causal components
linked to UFPs comes from European studies
that have used a nongravimetric PM measure
called black smoke, which is roughly represen-
tative of EC. Le Tertre et al. (2002) conducted
a time-series analysis of cardiovascular hospital
admissions in eight European cities and found
that CHD admissions were associated with
PM10 and black smoke. The association with
PM10, but not with black smoke, was reduced
by adding CO to the model and eliminated by
adding NO2. Both Le Tertre et al. (2002) and
the European study by Katsouyanni et al.
(2001) reported above hypothesized that their
results were attributable to trafﬁc exhaust and
its consequent high emissions of CO, NO2,
black smoke, and air toxics. It is relevant to
point out that traffic exhaust, particularly
from diesel engines, is a major contributor to
UFP mass in urban areas (Kittelson 1998;
Tobias et al. 2001), and in general, UFPs are
both strongly linked to mobile source emis-
sions and laden with toxic constituents (Kim
et al. 2002; Shi et al. 2001).
Although time-series investigations have
provided important information regarding
the overall public health impact of ambient
air pollutants on severe outcomes such as
mortality, studies of individual subjects have
provided insights into the underlying acute or
chronic exposure–response relationships.
Below we review studies of individuals using
various epidemiologic designs, including
cohort and panel studies, focusing only on
ﬁndings for cardiovascular outcomes. Details
for selected studies are presented in Table 1
and follow the discussion in the text.
Time-series studies have provided evidence
for acute effects of air pollutants on cardio-
vascular morbidity and mortality. However,
there are still gaps in the literature regarding
chronic health impacts from long-term pollu-
tant exposures. Cohort studies are best suited
to address this gap. Dockery et al. (1993)
reported evidence from the Harvard Six Cities
Study that ambient PM2.5 was associated with
risk of cardiopulmonary mortality in a cohort
of 8,111 adults (Table 1). Pope et al. (2004a)
used 16 years of data from more than
500,000 adults in 151 U.S. cities that partici-
pated in the Cancer Prevention Study II of
the American Cancer Society. The authors
found that a 10-µg/m3 elevation in PM2.5 was
associated with 8–18% increases in mortality
due to ischemic heart disease, dysrhythmias,
heart failure, and cardiac arrest. Mortality
from various respiratory causes was not associ-
ated with PM2.5 (Table 1). In contrast, a
cohort study of 6,338 Seventh Day Adventists
living in California found associations of
long-term exposure to PM and O3 with respi-
ratory mortality but not with cardiovascular
mortality (Abbey et al. 1999) (Table 1).
Differences in ﬁndings might be due to expo-
sure misclassiﬁcation from the use of central
regional air pollutant data. Hoek et al. (2002)
tried to address this issue by evaluating effects
of trafﬁc exposures near the home in a cohort
study of 5,000 adults followed 8 years in the
Netherlands (Table 1). They showed that liv-
ing near a major road was more strongly asso-
ciated with cardiopulmonary mortality than
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Table 1. Cardiovascular effectsa associated with personal and ambient air pollution exposure: selected studies.
Studies Design and population Outcomes Findings for PM mass and components Findings for gases
Continued, next page
Cohort and cross-sectional studies
Dockery et al. 1993 Cohort study examining Cardiopulmonary Compared with the least polluted city, No association with O3, but
ambient air pollution mortality the most polluted city had an adjusted SO2 and NO2 tracked
exposure and mortality in RR for cardiopulmonary mortality of 1.37 between-city trends in PM
8,111 adults in six U.S. cities (95% CI, 1.11–1.68) concentrations
with 14–16 years of
follow-up
Pope et al. 2004a Cohort study examining Cardiovascular A 10-µg/m3 increase in PM2.5 was Not assessed
ambient PM exposure and mortality: associated with 8–18% increases in
cardiovascular mortality in ischemic heart mortality due to ischemic heart disease,
319,000–500,000 persons disease, dysrhythmias, heart failure, and cardiac
in the Cancer Prevention dysrhythmias, arrest
Study II, with 16 years of heart failure, and
follow-up across U.S. urban cardiac arrest
areas
Abbey et al. 1999 Cohort study examining Cardiopulmonary No associations No associations
ambient PM10 exposure, total mortality
suspended sulfates, SO2, O3,
and NO2 in relation to 
mortality in 6,338 non-
smoking California Seventh-
Day Adventists with 19 years 
of follow-up
Hoek et al. 2002 Cohort study examining Cardiopulmonary Cardiopulmonary mortality was Cardiopulmonary mortality
ambient trafﬁc-related air pol- mortality associated with living near high trafﬁc was associated with an
lutant exposure (black smoke, density (100 m to freeway or 50 m to increase of 30 µg/m3
NO2) and cause-speciﬁc major urban road) adjusted RR = 1.95 background plus local
mortality in 5,000 persons  (95% CI, 1.09–3.52) and was associated  NO2, RR 1.81 (95% CI,
with 8 years of follow-up with an increase of 10 µg/m3 black smoke 0.98–3.34)
in the Netherlands Cohort  from background (central sites) plus local 
Study on Diet and Cancer sources (street proximity), RR = 1.71 
(95% CI, 1.10–2.67)
Künzli et al. 2004 Cross-sectional study on the  CIMT For each increase of annual mean 10 µg/m3 Estimates for O3 linked to
relationship between ambient PM2.5, CIMT increased by 5.9% (95% CI,  ZIP code centroids were
PM2.5 and CIMT, using 1–11%); adjustment for age reduced  positive in relation to CIMT
baseline data from two  the coefﬁcients, but further adjustment  but not signiﬁcant and
clinical trials in Los Angeles; for covariates indicated robust estimates  smaller than PM2.5
annual mean PM2.5 exposure in the range of 3.9–4.3%
was estimated using data 
from 23 monitoring stations
linked to home addresses
with geostatistical models
Cardiac ischemia and related outcomes
Pekkanen et al. 2002 Panel study examining ECG ST segment Increased risk for ST depression (72 events)  NO2 and CO were also
ambient PM, NO2, and CO depression >  was associated with a change of lag-2  associated with an increased
exposure and ischemia 0.1 mV 1,000 particles/cm3 NC0.1–1, OR = 3.29 risk for ST depression.
during 342 submaximal (95% CI, 1.57–6.92), 10 µg/m3 PM2.5,
exercise tests in 45 subjects OR = 2.84 (95% CI, 1.42–5.66), and 10,000
with CHD in Helsinki, Finland UFP/cm3 NC0.01–0.1, OR = 3.14 (95% CI, 
1.56–6.32); UFPs were independent of 
PM2.5
de Hartog et al. 2003 Panel study examining Cardiorespiratory A 10-µg/m3 increase in PM2.5 associated Not assessed
ambient exposure to PM symptoms: chest  with shortness of breath, OR = 1.12 (95%
and NO2, SO2, and CO in pain, shortness of CI, 1.02–1.24) and avoidance of activi-
relation to HRV and BP in  breath,avoidance  ties, OR = 1.10 (95% CI, 1.01–1.19)
131 subjects with CHD in of activities
Helsinki, Finland; Amsterdam,
the Netherlands; and Erfurt,
Germany
Peters et al. 2004 Case-crossover study MI Exposure to trafﬁc was associated with As with PM, gases were not
examining ambient trafﬁc- onset of MI 1 hr afterward, OR = 2.92  directly assessed, but trafﬁc
related air pollution exposure  (95% CI, 2.22–3.83); a signiﬁcant  exposures involve pollutant
and MI in 691 subjects from association was also seen for exposure  gases as well as particles
the Augsburg Myocardial  to trafﬁc 2 hr before onset, and there 
Infarction Registry who had  was evidence for effects up to 6 hr;
survived 24 hr postinfarct;  key exposures inﬂuencing overall
time–activity diary data on associations with trafﬁc included times
activities during the 4 days  spent in cars and in public transportation;
before symptom onset were  associations changed minimally, adjusting 
used to assess trafﬁc for exercise, and there was no confounding 
exposures by reports of extreme anger or joyCardiovascular health and ultrafine particles
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Table 1. Continued
Studies Design and population Outcomes Findings for PM mass and components Findings for gases
Continued, next page
Blood pressure (BP)
Linn et al. 1999 Panel study in Los Angeles, BP Systolic BP increased 0.172 mm Hg for No association of BP with
California, examining BP and  every 1-µg/m3 increase in ambient lag-1 exposure to central site O3,
lung function in 30 subjects PM10 (p = 0.006); diastolic BP increased  NO2, or CO
with COPD, with only 4 con- 0.095 mm Hg for every 1-µg/m3 increase 
secutive days of air sampling:  in PM10 (p = 0.03); outdoor home PM10
personal exposure to PM2.5,  was similarly associated with BP, but no 
indoor and outdoor home  signiﬁcant associations were reported 
PM2.5 and PM10, and ambient  for PM2.5 or any indoor or personal PM
PM10, O3, NO2, and CO  measurement
Brauer et al. 2001 Panel study examining per- BP, HRV, SVE Weak associations were observed CO was inversely associated
sonal exposure over 7 non- between particle concentrations and with systolic BP and
consecutive days to PM2.5 increased SVE and with decreased reduced estimates for
and sulfate, and ambient  systolic BP; ambient PM10 had the ambient PM
exposure to PM2.5, PM10 ,  largest effect on cardiovascular end
sulfate, and gaseous pollu-  points and the only statistically signiﬁ-
tants, in relation to BP, HRV, ﬁcant association (SVE); use of personal
and lung function in 16 COPD exposure measurements did not show a
patients in Vancouver, Canada larger or more consistent effect
Ibald-Mulli et al. 2001 Retrospective analysis Systolic BP A 90-µg/m3 increase in TSP was An 80-µg/m3 increase in SO2
examining the relationship associated with an increase in systolic was associated with an
between ambient air BP of 1.79 mm Hg (95% CI, 0.63–2.95); increase in systolic BP of
pollution exposure (TSP, SO2, in subgroups with high plasma viscosity 0.74 mm Hg (95% CI,
and CO) and BP in 2,607 men levels or increased HR, systolic BP  0.08–1.40)
and women 25–64 years of  increased by 6.93 mm Hg (95% CI, 
age from a general population 4.31–9.75) and 7.76 mm Hg (95% CI, 
survey in Augsburg, Germany 5.70–9.82) in association with TSP,
respectively
Ibald-Mulli et al. 2004 Panel study examining BP and HR A small decrease in systolic BP The magnitude and
ambient exposure to PM and (–0.72 mm Hg; 95% CI, –1.92 to 0.49)  signiﬁcance of inverse BP
NO2, SO2, and CO in relation and diastolic BP (–0.70 mm Hg; 95% CI, associations with CO were
to HRV and BP in 131 subjects –0.02 to –1.38) was found to be associa- similar to those of PM0.1–1.0;
with CHD in Helsinki, Finland; ted with a 5-day average increase of  a small decrease in HR
Amsterdam, the Netherlands 10,000 UFPs/cm3 (NC0.01–0.1); slightly  (–0.40 beats/min; 95% CI,
and Erfurt, Germany stronger and more signiﬁcant associations –0.82 to 0.01) was found for
were found for accumulation mode  an increase of lag-1, 5 µg/m3
particle number concentration (NC0.1–1.0), SO2
but smaller associations were found 
for a 10 µg/m3 increase in PM2.5 mass; 
small decreases in HR were also 
found for PM exposures
Zanobetti et al. 2004 Panel study examining ambient  BP Increasing from the 10th to the 90th per- Diastolic BO was associated
PM2.5, O3, NO2, SO2, and CO  centile in 5-day mean PM2.5 (10.5 µg/m3) with 120-hr average SO2
in relation to BP among 62  resulted in increases of 2.8 mm Hg  (3.9% increase; 95% CI, 
patients with preexisting (95% CI, 0.1–5.5) in systolic, 2.7 mm Hg  0.3–76), O3 (2.7% increase; 
heart disease using data from  (95% CI, 1.2–4.3) in diastolic, and  95% CI, 0.02–5.4)
631 repeated visits for cardiac 2.7 mm Hg (95% CI, 1.0–4.5) in mean 
rehabilitation in Boston arterial BP; black carbon was associated
with diastolic BP
Autonomic control of cardiac rhythm
Holguin et al. 2003 Panel study in Mexico City HRV, frequency A 10-µg/m3 increase in predicted O3 was inversely associated
examining indoor and outdoor domain personal PM2.5 was associated with a with high- and low-frequency
nursing home measurements  5.0% decrease in high-frequency HRV HRV among 13 subjects with
of PM2.5 and ambient expo-  (β = –0.049; 95% CI, –0.090 to –0.007); hypertension (2% decrease
sure to O3, NO2, CO, and SO2 associations with indoor PM2.5 were per 10 ppb O3), but this
in relation to HRV in 34 elderly stronger than outdoor home PM2.5; association was confounded
residents followed every other among 13 subjects with hypertension, by PM2.5
day for 3 months; personal  the association with predicted personal
PM2.5 was predicted using  PM2.5 was stronger (–7.1%)
indoor and outdoor home 
PM2.5 plus time–activity data
Pope et al. 2004b Panel study of ambient HRV  A 100-µg/m3 increase in PM2.5 was Not assessed
exposure to PM and HRV associated with a 35 (SE = 8) msec
and blood markers in 88 decrease in SDNN and a 42 (SE = 11)
elderly subjects living in msec decrease in r-MSSD
Salt Lake City and Provo/
Orem, UtahDelfino et al.
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Studies Design and population Outcomes Findings for PM mass and components Findings for gases
Continued, next page
Autonomic control of cardiac rhythm
Magari et al. 2001, 2002a, 2002b Panel study examining HRV Each 100-µg/m3 increase in 3-hr Not assessed
personal exposure to PM in average PM2.5 (laser photometer light
relation to HRV in 20 scatter) was associated with a 1.4%
(Magari et al. 2002a), 40 (95% CI, –2.1 to –0.6%) decrease in
(Magari et al. 2001), and 39 5-min SDNN in the 20 subjects (Magari
(Magari et al. 2002b) et al. 2002a); in the 40 subjects, each
healthy boilermakers 1-mg/m3 increase in 4-hr average PM2.5
exposed to welding fumes was associated with a 2.66% (95% CI,
and residual oil ﬂy ash –3.75 to –1.58%) decrease in 5-min SDNN
SDNN (Magari et al. 2001); however,
in 39 of these 40 subjects, PM2.5 metals
on ﬁlters, lead and vanadium, were
associated with an increase in workday
average of the 5-min SDNN (Magari et al.
2002b)
Riediker et al. 2004 Panel study of in-vehicle HRV  In-vehicle 10-µg/m3 PM2.5 increase was NO2 and CO were not
exposure to PM and HRV associated with increased ectopic beats signiﬁcant
and blood markers of throughout exposure (20%, p = 0.005);
inﬂammation in 9 healthy PM2.5 was positively associated with
male North Carolina heart beat cycle length (6%, p = 0.01) as
Highway Patrol troopers well as HF HRV and SDNN the next
morning after exposure
Chan et al. 2004 Panel study in Taipei,Taiwan, HRV Personal exposure to NC0.02–1 was Not assessed
examining personal exposure associated with decreased in both
to submicrometer particles time-domain and frequency-domain
and HRV over one 16-hr HRV indices; in young subjects, a
daytime period in 9 young  10,000 particles/cm3 increase in the last
healthy adults 19–29 years 1–4 hr average NC0.02–1 was associated
of age (2 females) and 10  with 0.68–1.35% decrease in SDNN,
older male subjects 42–97 1.85–2.58% decrease in r-MSSD; in the
years of age with lung older panel they found 10,000-particles/cm3
function impairments increase in the last 1- to 3-hr average
(FEV1/FVC < 85%) NC0.02–1 was associated 1.72–3.00%
decreases in SDNN and 2.72–4.65%
decreases in r-MSSD; there were
similar associations for high- and
low-frequency domain indices
Tarkiainen et al. 2003 Panel study in Kuopio, HRV Not assessed r-MSSD increased by 2.4 
Finland, examining msec (p = 0.03) with 
personal exposure to exposure to CO (> 2.7 ppm)
carbon monoxide and HRV
in 6 subjects with CHD
followed for three separate
24-hr ambulatory
monitoring periods
Peters et al. 2000 Panel study of arrhythmias Deﬁbrillator Only 6 subjects with ≥ 10 deﬁbrillator 26-ppb increase in NO2
in 100 subjects in eastern discharge discharges had increased arrhythmias lagged 1 day was associated
Massachusetts with interventions for associated with black carbon and PM2.5,  with increased deﬁbrillator
implanted deﬁbrillators ventricular which showed a weaker association; interventions in the full
(63,628 person-days of tachycardias or both PM metrics were confounded by panel (OR = 1.8; 95% CI,
follow-up) with ambient ﬁbrillation NO2, but the effect estimate of NO2 was 1.1–2.9). Subjects with
measurements of PM mass, (33 subjects with unchanged ≥ 10 deﬁbrillator discharges
black carbon, NO2, CO, O3, at least one) had increased arrhythmias
and SO2 associated with CO and
NO2 across several lags
Systemic inﬂammation and thrombosis
Seaton et al. 1999 Panel study examining 3-day  Hematologic An increase of 100 µ/m3 in personal Not assessed
personal exposure estimated  factors: hemo- PM10 and ambient PM10 exposure
(from a one 24-hr personal  globin, packed resulted in signiﬁcant decreased mean
exposure measurement) and  red cells, red percentage changes of ≤ 1% in
city center ambient exposure blood cell count, hemoglobin concentration, packed cell
to PM10 in relation to hema- platelets, white volume, and red blood cell count; only
tologic factors in 112 elderly blood cell count, personal PM10 was associated with an
subjects in Belfast and  CRP, ﬁbrinogen, 11% decrease in platelets and a 7%
Edinburgh, UK factor VII, IL-6  decrease in factor VII; CRP increased
with ambient PM10 (+147%; 95% CI,
20–477), but not with personal PM
(p = 0.73); ﬁbrinogen decreased with
ambient PM10 (–9%; 95% CI, –19 to 0)with ambient background air pollutant levels.
This finding suggests that pollutants more
closely associated with traffic, which include
UFPs and associated toxic air pollutants,
could be causal components in the mortality
associations.
Künzli et al. (2004) conducted a cross-
sectional study of 798 healthy adults with
elevated low density lipoprotein (LDL) choles-
terol or homocysteine living on Los Angeles
(Table 1). Subjects were in a dietary supple-
ment clinical trial with ultrasound data on
carotid intima-media thickness (CIMT) as an
estimate of atherosclerosis. Exposure included
an estimate using geostatistical models to link
subject address to annual mean PM2.5 from
23 local air-monitoring stations. They found
positive associations between CIMT and
PM2.5, adjusting for host risk factors.
Associations were larger for women, older
subjects (≥ 60), subjects on lipid-lowering
medications, and never smokers.
Evidence for Pathophysiologic
Mechanisms and Causal
Components in PM-Related
Cardiovascular Effects
The following section looks at epidemiologic
panel studies designed to evaluate the relation-
ship between repeated air pollutant exposures
and cardiovascular outcomes in individual
subjects. We augment this discussion with a
few selected human clinical studies that extend
the panel study ﬁndings using controlled expo-
sures, particularly those that aim to replicate
ambient air mixtures. The discussion is divided
by related groups of cardiovascular outcomes.
Cardiac ischemia and related outcomes.
One published study has examined evidence for
the relationship of particulate air pollutant
exposure to cardiac ischemia in humans. An
epidemiologic study of 45 adults with stable
CHD conducted by Pekkanen et al. (2002)
analyzed data from repeated biweekly in-clinic
electrocardiographic (ECG) measurements dur-
ing submaximal exercise testing and outdoor
UFPs and ﬁne particles measured at a central
regional site of Helsinki, Finland (Table 1).
They found significant associations between
risk of ST segment depression and ambient
PM2.5 mass, number concentrations of ultraﬁne
mode particles 0.01–0.1 µm in diameter
(NC0.01–0.1), and number concentrations of
accumulation-mode particles 0.1–1.0 µm in
diameter (NC0.1–1) (Table 1). Odds ratios
(ORs) were around 3.0 for all particle metrics
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Table 1. Continued
Studies Design and population Outcomes Findings for PM mass and components Findings for gases
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Schwartz 2001 Cross-sectional study Fibrinogen, and For an interquartile range change in SO2 was positively
examining the relationship platelet and white PM10 (26 µg/m3), the relative odds for associated with white cell 
between ambient PM10, blood cell counts being above the 90th percentile of counts, and NO2 with 
NO2, SO2, and blood ﬁbrinogen was 1.77 (95% CI, 1.26–2.49); platelet counts and ﬁbrino-
biomarkers using data from platelets, 1.27 ( 95% CI, 0.97–1.67); gen, but both gases were
a cohort study (NHANES III) and white blood cells, 1.64 (95% CI, confounded by PM10
1.17–2.30)
Pekkanen et al. 2000 Cross-sectional study Fibrinogen No association between PM10 and NO2 increase from the 10th
examining the association ﬁbrinogen was seen after adjustment to the 90th percentile was
between ambient PM10, for confounders associated with a 1.5%
NO2, CO, SO2, O3, and higher ﬁbrinogen concentra-
ﬁbrinogen among 7,205 tion (95% CI, 0.4–2.5%);
subjects in London at similar increase for CO 
baseline enrollment in a resulted in 1.5% higher 
cohort study ﬁbrinogen concentration
(95% CI, 0.5–2.5%); no
association with SO2 or O3
Peters et al. 1997a, 2001b Cohort study in Augsburg, CRP An increase of 26 µg/m3 (5-day mean) An increase of 30 µg/m3
Germany, examining in TSP increased the odds of observing (5-day mean) in SO2
relationships of ambient TSP, a CRP level above the 80th percentile, increased the odds of
SO2, and CO exposure to CRP OR = 1.31 (95% CI, 1.09–1.56); CRP observing a CRP level
in 631 men 45–64 years and plasma viscosity (Peters et al. above the 90th percentile,
of age with no history of MI 1997a) were increased during an air OR = 1.24 (95% CI,
at their baseline assessment; pollution episode in 1985 1.03–1.49)
two CRP measurements were 
3 years apart
Pope et al. 2004b Panel study of ambient CRP, white blood A 100-µg/m3 increase in PM2.5 was Not assessed
exposure to PM and HRV cell count, whole associated with a 0.81 (SE = 0.17)
and blood markers in blood viscosity, mg/dL increase in CRP; one subject’s
88 elderly subjects living in granulocytes, data had a strong inﬂuence on
Salt Lake City and Provo/ lymphocytes, estimates; there was no association
Orem, Utah monocytes, with other outcomes
basophils,
eosinophils,
red blood cells,
platelets
Riediker et al. 2004 Panel study of in-vehicle CRP, plasminogen, In-vehicle 10-µg/m3 PM2.5 increase was NO2 and CO were not
exposure to PM and HRV von Willebrand associated with decreased lymphocytes signiﬁcant
and blood markers of factor, lymphocyte (–11%, p = 0.03), increased red blood
inﬂammation in 9 healthy count, lymphocytes, cell indices (1%, p = 0.03), neutrophils
male North Carolina neutrophils,  (6%, p = 0.04), CRP (32%, p = 0.02),
Highway Patrol troopers hematocrit, red and von Willebrand factor (12%,
blood cell indices, p = 0.02)
uric acid
Abbreviations: FEV1/FVC, forced expiratory volume in 1 sec/forced vital capacity; HF, high frequency; RR, relative risk; SVE, supraventricular ectopic heartbeat. 
aThe focus is on cardiovascular outcomes. Although some studies may have examined other outcomes, they are not reported.for an increase around their interquartile
distribution. Smaller but significant associa-
tions were also found for the gases NO2 and
CO, which were moderately correlated with
the co-located particle measurements. The
association with UFP number concentration
was independent of PM2.5 mass concentra-
tion. It is surprising that associations for out-
door ambient NC0.01–0.1 were as strong as for
PM2.5, given the expectation that human
exposure to UFPs is less consistently repre-
sented by central site PM monitoring than is
exposure to PM2.5 monitoring, which shows
much lower spatial variability than UFPs
(reviewed by Pekkanen and Kulmala 2004;
Sioutas et al. 2005).
Cardiorespiratory symptoms potentially
related to cardiac ischemia were assessed by
de Hartog et al. (2003) in elderly patients
with CHD. The authors found that although
chest pain was not associated with PM expo-
sure, a 10 µg/m3 increase in ambient PM2.5
was associated with shortness of breath and
avoidance of activities (Table 1).
A case-crossover study of 691 subjects from
the Augsburg Myocardial Infarction Registry
found a 2- to 3-fold increased risk of MI for
time–activity diary reports of hours exposed to
trafﬁc, particularly for times spent in cars and
public transportation in the hours leading up
to cardiac symptom onset (Peters et al. 2004)
(Table 1). No direct air pollutant measure-
ments were available. However, as discussed in
our companion article (Sioutas et al. 2005),
exposures to UFPs can be magnitudes higher
than background levels within vehicles and
near busy highways, and to a much greater
degree than larger particles. Accumulation-
mode PM, volatile organic compounds, and
gases such as CO could have also played a role
in the ﬁndings of Peters et al. (2004).
Blood pressure. Two studies showing asso-
ciations between air pollution and blood pres-
sure (BP) followed subjects with COPD
(Brauer et al. 2001; Linn et al. 1999; Table 1).
Linn et al. (1999) found that for only 120 total
person-observation times in 30 subjects, an
increase of 33 µg/m3 ambient PM10 (study
mean) was associated with a 5.7 mm mercury
(Hg) increase in systolic BP. In contrast,
Brauer et al. (2001) found systolic BP was
inversely but weakly associated with personal
PM2.5 in a pooled regression analysis of
16 subjects with COPD monitored on 7 sepa-
rate days. This association was not confounded
by inverse associations with ambient CO.
Inverse associations with ambient PM10 were
larger but were confounded by CO. Another
study examined 2,607 German adults younger
than 65 years evaluated on two occasions
3 years apart and found a positive association
of systolic BP with ambient concentrations of
both total suspended particulates (TSP) and
SO2 (Ibald-Mulli et al. 2001) (Table 1).
Ibald-Mulli et al. (2004) conducted one
of the few panel studies to focus on the rela-
tionship between UFPs and BP (Table 1).
They followed 131 adults with CHD in three
European centers every 2 weeks for about
11 clinic visits. An increase of a 5-day average
of 10,000/cm3 UFPs (PM0.01–0.1) was associ-
ated with small decrease in systolic BP
(–0.72 mm Hg; p < 0.01) and diastolic BP
(–0.70 mm Hg; p < 0.01). Comparably small
associations were also found for CO,
1,000/cm3 accumulation-mode particles, and
10 µg/m3 PM2.5. The authors hypothesized
that BP medications in these CHD patients
might have blunted or modiﬁed the response
to air pollution exposure. However, these
results contrast those of a panel study by
Zanobetti et al. (2004), who found that
ambient 5-day average PM2.5 was positively
associated with BP among 62 patients with
preexisting heart disease, using data from
631 repeated visits for cardiac rehabilitation
in Boston (Table 1).
Panel study results for PM2.5 can be com-
pared with two experimental human studies
(Brook et al. 2002; Gong et al. 2003; not
shown in Table 1). Gong et al. (2003) studied
the effects of PM2.5 concentrated ambient par-
ticles (CAPs) from Los Angeles air versus clean
air on systolic BP in 12 healthy versus 12 asth-
matic adults using a 2-hr rest–exercise exposure
period in a chamber. CAPs are used to approx-
imate the effects of “real-world” particles. They
found inverse associations of PM2.5 CAPs with
systolic BP in asthmatics, but positive associa-
tions in healthy subjects. Results from two
small studies by Brauer et al. (2001) and Gong
et al. (2003) with relatively good exposure data
show that PM2.5 mass is inversely associated
with BP in subjects with obstructive lung dis-
eases. Brook et al. (2002) also studied the vas-
cular effects of 150 µg/m3 PM2.5 CAPs from
Toronto air, adding 120 ppb O3, in 25 healthy
adults using a 2-hr exposure period in a cham-
ber. They found a significant but small
0.1 mm decrease in brachial artery diameter by
ultrasonography for the joint exposures versus
ﬁltered air but no change in BP, ﬂow-mediated
diameter (endothelium dependent), or nitro-
glycerin-mediated dilatation (endothelium
independent). A follow-up analysis showed
that the organic and EC fractions of PM2.5
CAPs were significant determinants of the
effects on brachial artery diameter, which is a
more sensitive biomarker of effect than BP
(Urch et al. 2004).
Potential mechanisms for the observed
PM-associated increases in BP have been sug-
gested to include an increase in sympathetic
tone and/or the modulation of basal systemic
vascular tone due to increased concentrations
of a plasma peptide known as endothelin-1
(Ibald-Mulli et al. 2001). Endothelin-1
has multiple cardiovascular actions, including
vasoconstriction, leading to maintenance of
basal vascular tone and BP (Haynes and Webb
1998) and accentuating BP elevation in
more severe, sodium-sensitive hypertension
(Schiffrin 2001). It is directly associated with
the severity of CHF and risk of subsequent car-
diac death in CHF patients (Galatius-Jensen et
al. 1996; Tsutamoto et al. 1995). Endothelin-1
is produced and cleared in the lung and is gen-
erated in response to the presence of ROS (free
radicals) and their metabolites (Haynes and
Webb 1998). This leaves open the possibility
that pollutants could induce an excess produc-
tion of endothelin-1. Supporting evidence is
that urban particles have been shown to
increase endothelin-1 in rats (Bouthillier et al.
1998). Effects of endothelin-1 are partly coun-
terbalanced by vasodilatory influences of
endothelial nitric oxide (NO; Vanhoutte
2000). Endothelial NO synthase produces
NO, which traverses the extracellular space to
induce smooth muscle relaxation in the vessel
wall. One ROS that can be produced in the
presence of certain pollutant components is
superoxide, which can react with NO to form
the potent oxidant peroxynitrite. Peroxynitrite
is likely involved in lipid peroxidation
(O’Donnell and Freeman 2001). Therefore, an
additional potential mechanism whereby pol-
lutant components can increase BP includes
superoxide-mediated inhibition of the actions
of NO in inducing vasodilatation.
Despite the above data on potential bio-
logic mechanisms, reviewed epidemiologic
studies have found both a decrease and increase
in BP in relation to air pollutant exposures.
This may be because of differences between
subject populations, differences in the types of
regional air pollutants, or possibly due to medi-
cations used or underlying pathology (healthy,
COPD, asthma, CHD, etc.). There is also a
lack of data in most studies on other inﬂuences
on BP, namely, emotional states and physical
activity, which could have sustained inﬂuence
on nonambulatory BP measurements. The
above factors could result in contrasting shifts
in sympathetic and vagal tone in response to
inhaled air pollutants, or contrasting shifts in
the balance between mediators such as
endothelin-1 and endothelial NO. The time
course of exposure–response relationships is
also ill-deﬁned, particularly periods of exposure
averaging times ranging from minutes to days.
None of the epidemiologic studies used ambu-
latory BP monitoring to assess acute effects of
real time changes in exposure. Ambulatory BP
monitoring is more closely associated with end
organ damage (heart, kidney, brain) than iso-
lated systolic or diastolic BP readings taken in
clinic ofﬁces (Mancia and Parati 2000).
Autonomic control of cardiac rhythm.
Heart rate variability (HRV) is a widely used
noninvasive method to investigate cardio-
vascular autonomic control. Reduced HRV has
Delfino et al.
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tality after MI (Kleiger et al. 1987; La Rovere
et al. 1998) and has been related especially to
sudden arrhythmic death (Hartikainen et al.
1996; Odemuyiwa et al. 1991). Fourier analy-
sis of HRV can show the magnitude of vari-
ance in the heart’s rhythm across different
frequency bands. Different autonomic influ-
ences on cardiovascular function (HR and BP)
are reﬂected by different frequency bands. The
high-frequency (HF) band (0.15–0.40 Hz) has
been used to estimate cardiac vagal control and
is linked to respiratory inﬂuences (Task Force
1996). Lower frequencies (0.04–0.15 Hz) are
believed to represent mixed sympathetic and
parasympathetic inﬂuences (Task Force 1996).
Time domain measurements are also used
(described below).
One controlled exposure study showed
significant decreases in HRV in 10 healthy
elderly adults for 2-hr exposures to CAPs from
Chapel Hill, North Carolina (mostly mobile
source) compared with clean air, and the
decrease persisted 24 hr later (Devlin et al.
2003). In epidemiologic studies discussed
below, ambient PM has been associated with
decreased HRV (Chan et al. 2004; Creason
et al. 2001; Gold et al. 2000; Holguin et al.
2003; Liao et al. 1999; Magari 2002, Magari
et al. 2001, 2002; Peters et al. 1999; Pope et al.
2004b, 1999) and cardiac arrhythmia (Peters
et al. 2000). Only two studies to our knowl-
edge have investigated effects of personal PM
exposures on HRV (Chan et al. 2004; Magari
et al. 2001), and one on personal CO
(Tarkiainen et al. 2003).
Liao et al. (1999) showed that the largest
inverse associations between nonambulatory
HRV measures and PM2.5 were for subjects
with a history of cardiovascular conditions,
although the number subjects (18) was small
and the specific illnesses were not separated
(not shown in Table 1). Another study of
56 elderly subjects showed inverse associations
of nonambulatory high- and low-frequency
HRV with indoor and outdoor 24-hr gravi-
metric PM2.5 collected in a retirement home
(Creason et al. 2001; not shown in Table 1).
Using hourly ambient PM2.5 data, they brieﬂy
reported that models using prior 4-hr average
PM2.5 and time-lagged 4-hr PM2.5 were similar
in magnitude to effects of the 24-hr PM2.5
averages, suggesting a mixture of short-term
and cumulative effects. Holguin et al. (2003)
studied 34 elderly nursing home residents
living in Mexico City and showed a strong
decrease in the high-frequency component of
HRV with high ambient PM2.5 exposure, and
the association was stronger for indoor home
PM2.5. Those with hypertension had the
largest reductions in HRV (Table 1). Pope
et al. (1999) also used ambulatory HR moni-
toring in 7 elderly subjects with respiratory
and cardiovascular disease before, during, and
after episodes of elevated pollution. They
found that ambient PM10 was associated with
decreased in the standard deviation (SD) of
normal-to-normal (NN) intervals (SDNN), a
time domain measure of overall HRV.
However, they also found an increase in the
square root of the mean of squared differences
between adjacent NN intervals (r-MSSD;
time domain measurement that corresponds
to high-frequency variability and parasympa-
thetic tone). A larger study using ambulatory
ECG monitors by Pope et al. (2004b) found
that ambient PM2.5 was associated with a
decrease in both SDNN and r-MSSD in
88 elderly subjects in Utah (Table 1). Magari
et al. (2001) studied 40 workers occupationally
exposed to welding fumes and residual oil ﬂy
ash with 24-hr monitoring using ambulatory
HR monitors and personal real-time PM2.5
measurements from a TSI Inc. DustTrak
(Shoreview, MN) (Table 1). They found sig-
niﬁcant decreases in SD of average 5-min NN
intervals in relation to increases in prior 1-hr
moving averages of PM2.5. They also found
increasingly greater decreases in SDNN for
higher PM2.5 across longer PM2.5 averaging
times up to 9 hr. Magari et al. (2001) sug-
gested inhaled particles directly affect auto-
nomic function through a sympathetic stress
response, represented by their acute response
finding, and/or secondarily through airway
inﬂammation and cytokine release into the cir-
culation, represented by their cumulative
response ﬁnding. Riediker et al. (2004) placed
portable air-quality monitors in patrol cars of
nine healthy male North Carolina Highway
Patrol troopers who wore ambulatory ECG
monitors (Table 1). In-vehicle PM2.5 was posi-
tively associated with ectopic beats, heart beat
cycle length, HF HRV, and SDNN.
Chan et al. (2004) conducted the only
study to date to assess the relationship between
HRV and particle number concentrations
(dominated by UFPs) for particles 0.02–1.0 µm
in diameter (NC0.02–1) (Table 1). They fol-
lowed 9 young healthy adults (2 females) and
10 elderly male subjects with obstructive lung
function impairment. This was also the first
study to examine the effects of personal expo-
sure to UFPs on HRV. Subjects were moni-
tored over only 10 daytime hours using a
P-Trak Ultraﬁne Particle Counter (TSI Inc.)
for NC0.02–1. Subjects also wore ambulatory
ECG monitors for continuous 5-min beat-to-
beat intervals to assess HRV. Using linear
mixed-effects models, they found that
decreases in HRV indices (SDNN and
r-MSSD) were associated with exposure to
1- to 4-hr moving averages of NC0.02–1 before
the 5-min HRV measurements, adjusting for
age, sex, body mass index, environmental
tobacco smoke exposure, and temperature
(Table 1). Associations were stronger for the
elderly panel, with the strongest effects from
2-hr average NC0.02–1. These results along with
those of Magari et al. (2001) suggest that the
effect of personal PM exposure on autonomic
function is acute, although the monitoring
period (10 hr) was too short in the Chan et al.
(2004) study to assess longer-term effects.
Tarkiainen et al. (2003) studied six
patients with CHD for 1 day per week for
3 weeks with continuous personal CO expo-
sure monitors, ambulatory ECG monitoring
for HRV, and time–activity diaries and found
r-MSSD increased in relation to high CO
exposures (> 2.7 ppm peaks lasting 17 min,
SD 8 min) (Table 1). This result contrasted
results of most studies using PM exposures,
except the study of Pope et al. (1999). No
particle data were available, but it is again
important to note that outdoor CO at sites
close to dense trafﬁc is highly correlated with
UFPs (Zhu et al. 2002). It is conceivable that
CO and/or UFPs increase vagal control and
induce bradyarrhythmias.
In a study of arrhythmias and air pollu-
tion, investigators followed 100 subjects in
eastern Massachusetts with implanted defib-
rillators (Peters et al. 2000; Table 1). They
found that patients with 10 or more deﬁbril-
lator discharge interventions for cardiac
arrhythmias experienced increased arrhyth-
mias in association with outdoor ambient
NO2, CO, and black carbon, but PM2.5 was
less strongly related. The most robust associa-
tion was found for NO2, which may have
been a marker for local traffic-related pollu-
tion, whereas particle mass may have been
additionally influenced by other sources.
Exposure was represented by only one Boston
monitoring site.
Systemic inflammation and thrombosis.
The view that air-pollution–induced airway
inﬂammation triggers systemic hypercoagula-
bility (Seaton et al. 1995) has been supported
in recent epidemiologic studies. It is relevant in
this regard that, compared with unaffected
people, patients with CHD (Lagrand et al.
1999; Mendall et al. 1997; Stec et al. 2000;
Woods et al. 2000) or a complication of
CHD, CHF (Pye et al. 1990; Torre-Amione
et al. 1996), have increased levels of inﬂamma-
tory cytokines such as interleukin (IL)-1β and
IL-6, and tumor necrosis factor-α (TNF-α).
They also have increased levels of circulating
acute phase proteins such as C-reactive protein
(CRP) and ﬁbrinogen. In patients with CHD,
CRP is also a strong independent predictor of
future coronary events (Rifai and Ridker 2001).
Cohort studies have shown that levels of acute
phase proteins, cytokines, and hemostatic fac-
tors indicative of a thrombophilic state or
endothelial activation are elevated at baseline in
subjects at risk for future coronary occlusion or
cardiovascular mortality (Cushman et al. 1999;
Danesh et al. 2000; Folsom et al. 2001; Harris
et al. 1999; Haverkate et al. 1997; Jager et al.
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Malik et al. 2001; Ridker 2001; Ridker et al.
2000, 2001; Thompson et al. 1995). Air pollu-
tant exposures that lead to acute increases in
already elevated levels of inflammatory and
hemostatic factors may also precipitate adverse
health outcomes. This is a strong possibility in
patients with diagnosed or underlying CHD, a
population most likely driving the time-series
associations. In addition, high air pollutant
exposures that lead to chronic or repeated
increases in systemic inflammation through
oxidative stress responses to ROS may promote
the progression of atherosclerosis in susceptible
individuals.
Recent studies have shown acute associa-
tions between air pollutant exposures and sys-
temic responses indicating inﬂammation and
hypercoagulability. Seaton et al. (1999) studied
112 elderly individuals and used 1 day of per-
sonal PM10 data per person to predict the
remaining 2 days using ambient (city center)
PM10 data (Table 1). Results showed inverse
associations of estimated personal PM10 with
albumin-adjusted hemoglobin, packed cell vol-
ume, red blood cell count, platelets, and
factor VII levels. They found no associations
between PM10 and IL-6 or white blood cell
count. Only ambient PM10 was positively asso-
ciated with CRP concentrations, but it was also
inversely associated with fibrinogen. The
authors hypothesized that particles enter lung
endothelial cells or erythrocytes and subse-
quently inﬂuence red cell adhesiveness, leading
to peripheral sequestration of red cells.
Contrasting results were found by Schwartz
(2001), who used health data from the Third
National Health and Nutrition Examination
Survey (NHANES III) in the United States
(Table 1). Results showed that outdoor PM10
levels on the day of subject visits or previous
day was positively associated with ﬁbrinogen
levels and counts of platelets and white blood
cells. Fibrinogen increased by 13 µg/dL
(95% CI, 4.6–22.1) for an interquartile range
change in PM10 of 26 µg/m3. PM effects were
independent of gaseous pollutants. Schwartz
(2001) argued that the NHANES III results
were consistent with data in controlled human
exposure (Ghio et al. 2000) and animal studies
(Gardner et al. 2000) that showed increased
plasma fibrinogen after particle exposures.
Pekkanen et al. (2000) found no association
between PM10 and fibrinogen using cross-
sectional data from another cohort study of
7,205 subjects in London. However, they did
ﬁnd associations between ﬁbrinogen and two
pollutant gases, NO2 and CO, but not SO2 or
O3. Epidemiologic studies in Augsburg,
Germany, have also shown positive associa-
tions of ambient air pollution with plasma vis-
cosity (Peters et al. 1997) and with CRP
concentrations (Peters et al. 2001b) (Table 1).
Another study of people exposed to forest ﬁre
smoke showed increased circulating levels of
IL-1β and IL-6 (Van Eeden et al. 2001; not
shown). A panel study by Pope et al. (2004b)
(Table 1) with 88 elderly subjects in Utah
showed a 0.81 mg/dL CRP increase in associa-
tion with a 100 µg/m3 increase in ambient
PM2.5. There was no association with white or
red blood cell counts, platelets, or whole-blood
viscosity. Riediker et al. (2004; discussed
above) assessed the relationship between
in-vehicle PM exposure and markers of inﬂam-
mation in nine healthy male state troopers. An
in-vehicle 10 µg/m3 PM2.5 increase was associ-
ated with decreased lymphocytes (–11%),
increased red blood cell indices (1%), neutro-
phils (6%), CRP (32%), and von Willebrand
factor (12%).
Summary and biologic plausibility. To
date only three studies have directly evaluated
the effects on cardiovascular health by UFPs or
particle number concentration (Chan et al.
2004; Ibald-Mulli et al. 2004; Pekkanen et al.
2002). Results of Pekkanen et al. (2002) show-
ing ST segment depression in relation to UFPs
are the most compelling ﬁndings. Associations
of ambient NC0.01–0.1 with ST segment
depression were independent of ambient
PM2.5, but it is unclear whether the ambient
exposure data represented personal UFP expo-
sures of subjects. Other indirect evidence that
components of fossil fuel combustion are
important comes from studies using surrogate
measures of particle composition such as black
smoke, proximity of homes to trafﬁc, or source
apportionment data. Epidemiologic associa-
tions for pollutant gases also seem to support
the idea that cardiovascular effects may be
linked to primary products of combustion
emissions that include UFPs.
Because hypertension, ST segment depres-
sion, and cardiac arrhythmias are well-known
risk factors for cardiac morbidity and mortal-
ity, the above findings of acute associations
with PM from individual-level studies are rele-
vant to the reported findings of time-series
and cohort investigations of mortality and
hospital morbidity. However, mixed ﬁndings
for BP have not provided a coherent view of
particle effects. Findings for HRV are largely
consistent in finding a decrease in HRV
except for the increase in r-MSSD with ambi-
ent PM among elderly subjects found by Pope
et al. (1999) and increased HF HRV for in-
vehicle PM among healthy men found by
Riediker et al. (2004). The clinical importance
of HRV to cardiovascular disease is unclear
however (Task Force 1996), and many techni-
cal issues regarding the inﬂuence of respiratory
patterns (respiratory sinus arrhythmia) and
psychosocial stress (both unmeasured in the
reviewed studies) remain unresolved (Sloan
et al. 1994).
The reviewed epidemiologic studies on cir-
culating biomarkers of effect show inconsistent
relationships between air pollution and
blood markers of inflammation and hyper-
coagulability, possibly because all but two stud-
ies used ambient exposure to PM. Currently,
only the studies of Seaton et al. (1999) and
Riediker et al. (2004) used any personal PM
exposure measurements, but results are not
consistent. In addition, the reviewed studies of
circulating biomarkers did not target people
with cardiovascular diseases, who are expected
to be among the most susceptible population,
as indicated in the time-series investigations.
The main limitation of most epidemio-
logic studies is exposure misclassiﬁcation from
dependence on central site rather than on per-
sonal or microenvironmental exposure data.
However, studies reported above that do have
personal exposure data also have limited num-
bers of subjects or days monitored. In general
some major methodologic issues that remain
involve choice of susceptible populations, per-
sonal exposure assessment, and timing of
measurements to assess the temporality of
exposure–dose–response relationships.
Despite the inconsistencies in epidemio-
logic data, sound postulated mechanisms sup-
port the biologic plausibility of many of the
ﬁndings. Airway inﬂammation from PM likely
involves inhalation of agents leading to the
deposition or production in lung tissue of
ROSs. The ROSs then induce subsequent oxi-
dant injury and inflammatory responses
(Pritchard et al. 1996; Schreck et al. 1991) both
in the lungs and systemically. Inhalation of par-
ticle-bound airborne transition metals (copper,
iron, nickel, vanadium) can lead to the produc-
tion of ROSs in lung tissue. Residual oil ﬂy ash
containing high concentrations of transition
metals but low in organic compounds have
been shown to induce in vitro increases in IL-6
mRNA in human epithelial cells (Quay et al.
1998). Dogs exposed to CAPs from Boston air
showed increased bronchoalveolar lavage
macrophages and increased circulating neutro-
phils in relation to a vanadium/nickel factor,
but no associations were shown with total
mass (Clarke et al. 2000). This suggests that
pollutant composition was important.
Organic constituents of PM are also capa-
ble of generating ROS. Nel et al. (2001) have
presented evidence that polycyclic aromatic
hydrocarbons (PAHs) from diesel exhaust par-
ticles (DEPs) and oxidized derivatives of
PAHs, such as quinones, lead to the generation
of ROSs and subsequent oxidant injury and
inﬂammatory responses, including the produc-
tion of nuclear transcription factor κB
(NF-κB). NF-κB increases the transcription of
cytokines and acute phase proteins (Schreck
et al. 1991). Evidence has been presented that
DEPs induce a broad polyclonal activation of
cytokines from an adjuvant-like activity of
DEP PAHs (Diaz-Sanchez et al. 1996, 1997;
Fujieda et al. 1998; Nel et al. 1998, 2001).
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increased neutrophils and B-lymphocytes in
lavage ﬂuids, increased expression of endothe-
lial adhesion molecules ICAM-1 (intercellular
adhesion molecule-1) and VCAM-1 (vascular
cell adhesion molecule-1) in bronchial biopsies,
and increased neutrophils and platelets in
peripheral blood (Salvi et al. 1999). Such
DEP-induced effects from oxidative stress
mechanisms would be expected to lead to
increased systemic hypercoagulability, but to
date supporting data in humans are limited.
Epidemiologic evidence in humans that
PM exposure increases biomarkers of oxidative
stress in blood is limited to one study of
50 healthy young adults in Copenhagen using
air samplers carried by subjects (Sorensen et al.
2003). They found a positive association
between personal black carbon exposure and
2-aminoadipic semialdehyde in plasma pro-
teins, a protein oxidation product. However,
no association with personal PM2.5 mass was
found, suggesting that traffic-related causal
components may have been better represented
by black carbon than by particle mass. A lipid
peroxidation product (malondialdehyde), as
well as red blood cell counts and hemoglobin
concentrations, was positively associated with
PM2.5 exposure in women only.
There are also plausible linkages between
pulmonary and cardiovascular responses to
PM. Airway inflammatory responses have
been demonstrated in animals exposed to par-
ticulate air pollutants (U.S. EPA 2003). As
discussed above, there is growing evidence that
airway responses may trigger systemic inﬂam-
mation and hypercoagulability. In addition,
PM can induce neurogenic inflammation in
the lungs from activation of capsaicin-sensitive
irritant receptors, leading to the release of
tachykinins from sensory terminals and then
airway inﬂammation and bronchoconstriction
(Veronesi and Oortgiesen 2001). This
response could then affect cardiovascular auto-
nomic function (Carr and Undem 2001;
Yeates 2000), but it is not yet clear to what
extent these mechanisms explain epidemio-
logic ﬁndings of air pollutant associations with
cardiac rhythm and BP. There is limited evi-
dence for an effect of tachykinins on cardiac
function (Maggi 1996). In addition, the link-
age between airway inflammation, cytokine/
chemokine release, and autonomic stress
response has not been directly demonstrated
in humans. There are some in vitro data linking
actions of pro-inﬂammatory cytokines IL-1β
and TNF-α to myocardial cell changes in con-
tractility and action potentials (DeMeules et al.
1992; Finkel et al. 1992; Li and Rozanski
1993; Yokoyama et al. 1993) and to induction
of arrhythmias (Weisensee et al. 1993).
There are experimental data indirectly
supporting a linkage between cellular inﬂam-
mation in the lungs and cardiovascular
responses to air pollutants. An experiment in
hyperlipidemic rabbits showed that intrapha-
ryngeal instillation of ambient urban PM10 led
to an increase in circulating polymorphonu-
clear neutrophils and caused an increase in the
volume fraction of atherosclerotic lesions,
which correlated with the number of alveolar
macrophages that phagocytosed PM10 in the
lung (r = 0.5) (Suwa et al. 2002). Particle-
induced airway inflammation and trans-
location of UFPs and other pollutants into the
circulation could lead to an increase in throm-
bogenic and inflammatory activity in the
blood and to a disturbance in cardiovascular
function. These extrapulmonary effects are
expected to increase the risk of adverse cardio-
vascular outcomes such as hospitalization.
Other evidence links airway inﬂammation
with cardiovascular effects. Cohort data have
shown links of COPD with CHD risk inde-
pendent of other risk factors (Jousilahti et al.
1999; Wedzicha et al. 2000), suggesting that
pulmonary inﬂammatory processes may have
pro-inflammatory effects on the vascular
endothelium. This could occur in individuals
with asthma or COPD who have depleted
antioxidant defenses from oxidative stress
compared with normal subjects, and their
defenses are further lowered during disease
exacerbations (Rahman et al. 1996). Zanobetti
et al. (2000a) have shown that a positive asso-
ciation between hospital admissions for car-
diovascular diseases and ambient air pollution
was nearly doubled in elderly patients admit-
ted with concurrent respiratory infections.
Diabetics appear to be another susceptible
group, with stronger associations between car-
diovascular hospital admissions and ambient
air pollution (Zanobetti and Schwartz 2001).
Several excellent reviews of experimental
data examining acute pulmonary and cardio-
vascular responses to inhaled UFPs and fine
particles have proposed pathophysiologic mech-
anisms (American Thoracic Society 1999;
Dhalla et al. 2000; Donaldson et al. 2001;
Godleski et al. 2000; MacNee and Donaldson
2000; Nel et al. 2001; Utell and Frampton
2000; Utell et al. 2002; van Eeden and Hogg
2002). We have synthesized these and other
data into the following proposed sequence
of events for UFPs that link pulmonary and
cardiovascular end points (Figure 1). Most of
these mechanisms likely also apply to larger PM
size fractions, particularly soluble components
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Figure 1. Hypothesized pathways leading to adverse cardiovascular health effects from exposure to UFPs. 
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of PM2.5, and retained nonsoluble particles in
the lung that may stimulate the bone marrow
to induce similar systemic responses (van Eeden
and Hogg 2002):
• UFP exposure is followed by high pulmonary
deposition (Chalupa et al. 2004; Daigle et al.
2003; International Commission on
Radiological Protection 1994). UFPs and
associated air toxics translocate to the intersti-
tium and gain entry into the circulation
(Nemmar et al. 2002, 2004; Oberdörster
et al. 2002).
• Redox-active components of PM lead to the
production of ROSs in various cells in the
lungs, blood, and vascular tissues. 
• This is followed by oxidative stress responses
in pulmonary epithelium and pulmonary
vascular endothelium and in extrapulmonary
vascular endothelium, leading to the produc-
tion of oxidized phospholipids (especially
LDL), lipid peroxidation (e.g., 8-iso-
prostaglandin F2α), reduced antioxidant
capacity (e.g., increase in the ratio of oxi-
dized to reduced glutathione), and the pro-
duction of superoxide anions by endothelial
NADPH oxidase, all of which likely con-
tribute to atherogenesis. Genetic poly-
morphisms in key metabolic enzymes likely
play a role in susceptibility.
• Pulmonary and extrapulmonary peripheral
vascular oxidative stress results in the activa-
tion and mobilization of mononuclear
leukocytes and the expression of NF-κB,
followed by increases in pro-inflammatory
cytokines (e.g., IL-1β, IL-6, and TNF-α)
and endothelial cell activation.
• Emigration of inflammatory cells from
blood to tissue sites involves up-regulation
of adhesion molecules (VCAM-1, ICAM-1)
on vascular endothelium and circulating
leukocytes.
• Increased release of cytokines by activated
mononuclear cells in the lungs and in the
blood leads to initiation of hepatic synthesis
of acute phase proteins (e.g., CRP and ﬁb-
rinogen).
• A hypercoagulable state then occurs with
platelet activation, hemostasis, and blood
clot formation followed by fibrinolytic
activity; this increases the risk of a coronary
event. Cytokines may also have direct effects
on cardiac function.
• Endothelial cell activation also leads the
expression of endothelin-1, which induces
vasoconstriction, and increased systolic and
diastolic BP, and the expression of extra-
cellular superoxide dismutase (SOD). SOD
catalyzes superoxide (O2
. –) to H2O2, which
lowers endothelial NO-induced vasodilation.
Neuroinflammatory responses involving
tachykinins and catecholamines may also
affect cardiovascular autonomic tone.
•The systemic inflammatory response also
stimulates the bone marrow to release
leukocytes and platelets, and polymor-
phonuclear leukocytes increasingly sequester
in pulmonary capillaries to induce more
inﬂammation.
Conclusion
As presented in this review, numerous studies
have implicated particulate air pollution as an
important contributor to morbidity and mor-
tality from cardiovascular causes. Most of these
data have been epidemiologic and have used
available air pollution data from governmental
monitoring stations. Because such data are col-
lected to meet regulatory standards, they may
not meet the needs of researchers trying to
understand the causal pollutant components
that lead to speciﬁc adverse health effects. UFPs
and related toxic constituents and precursors
are examples of air pollutants that have not
been fully investigated, in part due to lack of
available data. To date, data from epidemio-
logic studies indirectly implicate traffic- and
other combustion-related pollutants, which
include UFPs. Exposure assessment issues for
UFPs are complex and need to be considered
before undertaking epidemiologic investigations
of UFP health effects (Sioutas et al. 2005).
A large body of evidence shows that
inﬂammation and oxidative stress are related to
both acute changes in cardiovascular health
and chronic processes, including atherosclero-
sis. It is likely that redox-active components in
UFPs from fossil fuel combustion reach target
sites in the lungs, vasculature, and heart to
induce inflammation and oxidative stress,
adding to the burden of known lifestyle risk
factors for cardiovascular disease such as diet,
tobacco smoke, and stress.
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